Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

New findings on the role of IFN-alpha in diabetes reported

Jan. 26, 1999

WHO maintains importance of male contraceptive research

Jan. 26, 1999

Hypoglycemic/hypoinsulinemic chromium complexes designed at Otsuka

Jan. 26, 1999

New insulin sensitizer is a coligand for PPARalpha and PPARgamma receptors

Jan. 25, 1999

FDA grants priority review to SB's Avandia

Jan. 22, 1999

Unigene obtains E.U. approval for injectable calcitonin product

Jan. 22, 1999

Novel squalene synthase inhibitors claimed by Nippon Kayaku

Jan. 22, 1999

JT reports novel antidiabetic agent that has advanced to clinical trials

Jan. 21, 1999

Nippon Kayaku patents novel squalene synthase inhibitors

Jan. 21, 1999

Tyrosine kinase and bone resorption inhibitor isolated from fungus by Takeda

Jan. 21, 1999

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...